Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation

Raloxifene hydrochloride (R-HCl), a BCS class II drug, remains a mainstay in the prevention and pharmacologic therapy of osteoporosis. Its absolute bioavailability, however, is 2% due to poor solubility and extensive first pass metabolism. The present study describes two simultaneous approaches to i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jha, Ram K., Tiwari, Sanjay, Mishra, Brahmeshwar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2011
Soggetti:
Research Article Theme: Advanced Technologies for Oral Controlled Release Guest Editors: Michael Repka, Joseph Reo, Linda Felton, and Stephen Howard
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3134648/
https://ncbi.nlm.nih.gov/pubmed/21562721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-011-9619-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi